In future studies, it would be useful to compare both lung adenocarcinoma metastatic cells and primary tumors to analyze EMA and lamin A expression, together with other EMT markers that are already known to evolve during tumor progression or metastasis. This evidence concerns the gene MUC1 and lung adenocarcinoma.